Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
Background: Transfusion-transmitted infections (TTIs) are one of the biggest threats to blood transfusion safety. Nucleic acid testing (NAT) in blood donor screening has been implemented in many countries to reduce the risk of TTIs. NAT shortens this window period, thereby offering blood centers a m...
Main Authors: | Rajesh Kumar, Sonia Gupta, Amarjit Kaur, Manvi Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | http://www.ajts.org/article.asp?issn=0973-6247;year=2015;volume=9;issue=2;spage=199;epage=202;aulast=Kumar |
Similar Items
-
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
by: Venkatakrishna Shyamala
Published: (2014-01-01) -
One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus
by: Jose Eduardo Levi, et al.
Published: (2013-06-01) -
Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India
by: Rekha Hans, et al.
Published: (2019-01-01) -
"Seroprevalence of Cytomegalovirus, Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Antibodies among Volunteer Blood Donors "
by: R Moniri, et al.
Published: (2004-10-01) -
"Seroprevalence of Cytomegalovirus, Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Antibodies among Volunteer Blood Donors "
by: R Moniri, et al.
Published: (2004-12-01)